Literature DB >> 28213095

Cytotoxicity of gold nanoparticles with different structures and surface-anchored chiral polymers.

Jun Deng1, Mengyun Yao1, Changyou Gao2.   

Abstract

Nanoparticles (NPs) can have profound effects on cell biology. However, the potential adverse effects of gold nanoparticles (AuNPs) with different surface chirality and structures have not been elucidated. In this study, monolayers of poly(acryloyl-l(d)-valine (l(d)-PAV) chiral molecules were anchored on the surfaces of gold nanocubes (AuNCs) and nanooctahedras (AuNOs), respectively. The l-PAV-AuNCs and d-PAV-AuNCs, or the l-PAV-AuNOs and d-PAV-AuNOs, had identical physicochemical properties in terms of size, morphology and ligand density except of the reverse molecular chirality on the particle surfaces, respectively. The l-PAV capped AuNCs and AuNOs exhibited larger cytotoxicity to A549 cells than the D-PAV coated ones, and the PAV-AuNOs had larger cytotoxicity than PAV-AuNCs when being capped with the same type of enantiomers, respectively. The cytotoxicity was positively correlated with the cellular uptake amount, and thereby the production of intracellular reactive oxygen species (ROS). STATEMENT OF SIGNIFICANCE: • Gold nanoparticles with different structure and surface chirality are fabricated. • The structure and surface chirality at the nanoscale can influence cytotoxicity and genotoxicity. • A new perspective on designing nanoparticles for drug delivery, bioimaging and diagnosis.
Copyright © 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chirality; Cytotoxicity; Gold nanoparticles; Nanoparticle structure; Poly(acryloyl-l(d)-valine

Mesh:

Substances:

Year:  2017        PMID: 28213095     DOI: 10.1016/j.actbio.2017.01.082

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  7 in total

1.  Diffusion Reflection Method for Early Detection of Oral Squamous Cell Carcinoma Specifically Targeted by Circulating Gold-Nanorods Bio-Conjugated to Anti-Epidermal Growth Factor Receptor.

Authors:  Dror Fixler; Abraham Hirshberg; Shiran Sudri; Hamootal Duadi; Florin Altman; Irit Allon; Ariel Ashkenazy; Ruchira Chakraborty; Ilya Novikov
Journal:  Int J Nanomedicine       Date:  2021-03-17

2.  Non plasmonic semiconductor quantum SERS probe as a pathway for in vitro cancer detection.

Authors:  Rupa Haldavnekar; Krishnan Venkatakrishnan; Bo Tan
Journal:  Nat Commun       Date:  2018-08-03       Impact factor: 14.919

3.  In vitro evaluation of the antitumor effect of bismuth lipophilic nanoparticles (BisBAL NPs) on breast cancer cells.

Authors:  Rene Hernandez-Delgadillo; Claudia María García-Cuéllar; Yesennia Sánchez-Pérez; Nayely Pineda-Aguilar; Marco Antonio Martínez-Martínez; Eyra Elvyra Rangel-Padilla; Sergio Eduardo Nakagoshi-Cepeda; Juan Manuel Solís-Soto; Rosa Isela Sánchez-Nájera; María Argelia Akemi Nakagoshi-Cepeda; Shankararaman Chellam; Claudio Cabral-Romero
Journal:  Int J Nanomedicine       Date:  2018-10-05

Review 4.  Gold Nanoparticles in Diagnostics and Therapeutics for Human Cancer.

Authors:  Priyanka Singh; Santosh Pandit; V R S S Mokkapati; Abhroop Garg; Vaishnavi Ravikumar; Ivan Mijakovic
Journal:  Int J Mol Sci       Date:  2018-07-06       Impact factor: 5.923

Review 5.  Chiral nanomaterials for tumor therapy: autophagy, apoptosis, and photothermal ablation.

Authors:  Zaihui Peng; Long Yuan; Juncheng XuHong; Hao Tian; Yi Zhang; Jun Deng; Xiaowei Qi
Journal:  J Nanobiotechnology       Date:  2021-07-22       Impact factor: 10.435

6.  Chiral polymer modified nanoparticles selectively induce autophagy of cancer cells for tumor ablation.

Authors:  Long Yuan; Fan Zhang; Xiaowei Qi; Yongjun Yang; Chang Yan; Jun Jiang; Jun Deng
Journal:  J Nanobiotechnology       Date:  2018-07-11       Impact factor: 10.435

7.  Size, Surface Functionalization, and Genotoxicity of Gold Nanoparticles In Vitro.

Authors:  Gerard Vales; Satu Suhonen; Kirsi M Siivola; Kai M Savolainen; Julia Catalán; Hannu Norppa
Journal:  Nanomaterials (Basel)       Date:  2020-02-06       Impact factor: 5.076

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.